• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats.

作者信息

Dwivedi Y, Rastogi R, Garg N K, Dhawan B N

机构信息

ICMR Centre for Advanced Pharmacological Research on Traditional Remedies, Central Drug Research Institute, Lucknow, India.

出版信息

Pharmacol Toxicol. 1992 Nov;71(5):383-7. doi: 10.1111/j.1600-0773.1992.tb00566.x.

DOI:10.1111/j.1600-0773.1992.tb00566.x
PMID:1333078
Abstract

D-Galactosamine (800 mg/kg, intraperitoneally) caused significant decrease in the activities of 5'-nucleotidase, glucose-6-phosphatase and cytochrome P450 and increase in activities of gamma-glutamyl transpeptidase, succinate dehydrogenase, acid phosphatase and acid ribonuclease in liver after 24 hr. The levels of RNA, protein and glycogen decreased while total lipids, phospholipids, cholesterol and lipid peroxides increased. It also increased the serum levels of transaminases, alkaline phosphatase and bilirubin while protein concentration decreased significantly. Oral administration of Picroliv (12 mg/kg/day for 7 days), a standardised iridoid glycoside fraction of Picrorhiza kurroa, significantly prevented the biochemical changes in liver and serum of galactosamine-toxicated rats. Kutkoside (12 mg/kg/day for 7 days) also protected against changes in most of the hepatic and serum constituents studied. Another iridoid glycoside from Picroliv, Picroside I, at the same dose level could only prevent toxicant-induced changes in acid phosphatase, phospholipids and lipid peroxides in liver and alkaline phosphatase in serum. Mixture of Picroside I and Kutkoside in the ratio of 1:1.5 at 12 mg/kg dose elicited lesser response than Picroliv.

摘要

相似文献

1
Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats.
Pharmacol Toxicol. 1992 Nov;71(5):383-7. doi: 10.1111/j.1600-0773.1992.tb00566.x.
2
Perfusion with picroliv reverses biochemical changes induced in livers of rats toxicated with galactosamine or thioacetamide.用苦味叶下珠素灌注可逆转由半乳糖胺或硫代乙酰胺中毒的大鼠肝脏中诱导的生化变化。
Planta Med. 1993 Oct;59(5):418-20. doi: 10.1055/s-2006-959722.
3
Picroliv protects against aflatoxin B1 acute hepatotoxicity in rats.
Pharmacol Res. 1993 Feb-Mar;27(2):189-99. doi: 10.1006/phrs.1993.1018.
4
Effects of picroliv, the active principle of Picrorhiza kurroa, on biochemical changes in rat liver poisoned by Amanita phalloides.
Zhongguo Yao Li Xue Bao. 1992 May;13(3):197-200.
5
Picroliv affords protection against thioacetamide-induced hepatic damage in rats.苦味叶下珠素对硫代乙酰胺诱导的大鼠肝损伤具有保护作用。
Planta Med. 1991 Feb;57(1):25-8. doi: 10.1055/s-2006-960009.
6
Biochemical changes induced in liver and serum of aflatoxin B1-treated male wistar rats: preventive effect of picroliv.黄曲霉毒素B1处理的雄性Wistar大鼠肝脏和血清中的生化变化:苦味叶下珠的预防作用。
Pharmacol Toxicol. 2001 Feb;88(2):53-8. doi: 10.1034/j.1600-0773.2001.088002053.x.
7
Hepatoprotective activity of picroliv against carbon tetrachloride-induced liver damage in rats.苦味叶下珠素对四氯化碳诱导的大鼠肝损伤的保肝活性。
Indian J Med Res. 1990 Jun;92:195-200.
8
Hepatocurative effect of picroliv and silymarin against aflatoxin B1 induced hepatotoxicity in rats.
Planta Med. 2000 Dec;66(8):709-13. doi: 10.1055/s-2000-9907.
9
Picroliv, picroside-I and kutkoside from Picrorhiza kurrooa are scavengers of superoxide anions.胡黄连中的胡黄连苷、胡黄连苷-I和库特科苷是超氧阴离子清除剂。
Biochem Pharmacol. 1992 Jul 7;44(1):180-3. doi: 10.1016/0006-2952(92)90054-m.
10
Prevention of galactosamine-induced hepatic damage by picroliv: study on bile flow and isolated hepatocytes (ex vivo).苦味叶下珠预防氨基半乳糖诱导的肝损伤:胆汁流量及离体肝细胞研究(体外实验)
Planta Med. 1993 Feb;59(1):37-41. doi: 10.1055/s-2006-959600.

引用本文的文献

1
Pharmacological and Clinical Efficacy of and Its Secondary Metabolites: A Comprehensive Review.及其次生代谢产物的药理和临床疗效:全面综述。
Molecules. 2022 Nov 29;27(23):8316. doi: 10.3390/molecules27238316.
2
Picrorhiza kurroa, Royle ex Benth:Traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease.胡黄连:传统用途、植物药理学及在脂肪肝疾病治疗中的转化潜力 。罗伊尔氏胡黄连,由本瑟姆根据罗伊尔的标本定名:传统用途、植物药理学及在脂肪肝疾病治疗中的转化潜力
J Ayurveda Integr Med. 2023 Jan-Feb;14(1):100558. doi: 10.1016/j.jaim.2022.100558. Epub 2022 Jun 2.
3
An integrative approach to develop computational pipeline for drug-target interaction network analysis.
综合方法开发药物-靶标相互作用网络分析的计算流程。
Sci Rep. 2018 Jul 6;8(1):10238. doi: 10.1038/s41598-018-28577-6.
4
Enhances -Cell Mass Proliferation and Insulin Secretion in Streptozotocin Evoked -Cell Damage in Rats.增强链脲佐菌素诱发的大鼠胰岛β细胞损伤中的β细胞团增殖和胰岛素分泌。
Front Pharmacol. 2017 Aug 22;8:537. doi: 10.3389/fphar.2017.00537. eCollection 2017.
5
Modular Design of Picroside-II Biosynthesis Deciphered through NGS Transcriptomes and Metabolic Intermediates Analysis in Naturally Variant Chemotypes of a Medicinal Herb, .通过对一种药用植物自然变异化学型的NGS转录组和代谢中间体分析解析胡黄连苷II生物合成的模块化设计
Front Plant Sci. 2017 Apr 11;8:564. doi: 10.3389/fpls.2017.00564. eCollection 2017.
6
Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.氟康唑和米替福新联合免疫调节剂——苦马豆素抗利什曼原虫疗效。
Parasitol Res. 2011 Apr;108(4):793-800. doi: 10.1007/s00436-010-2230-2. Epub 2011 Jan 7.
7
Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.苦味叶下珠的免疫调节作用及其在治疗小鼠抗药性约氏疟原虫(多重耐药)感染中的潜力。
Pharm Res. 2008 Oct;25(10):2312-9. doi: 10.1007/s11095-008-9631-2. Epub 2008 Jun 13.
8
Ayurveda and traditional Chinese medicine: a comparative overview.阿育吠陀医学与传统中医:比较概述。
Evid Based Complement Alternat Med. 2005 Dec;2(4):465-73. doi: 10.1093/ecam/neh140. Epub 2005 Oct 27.
9
Picroliv -- a natural product protects cells and regulates the gene expression during hypoxia/reoxygenation.
Mol Cell Biochem. 1999 Apr;194(1-2):271-81. doi: 10.1023/a:1006982028460.